Skip to: Content
Skip to: Site Navigation
Skip to: Search
TUESDAY, FEBRUARY 9, 2010
 |  Follow Newser on Twitter   Friend Newser on Facebook   Subscribe to Newser's RSS feeds   Subscribe to Newser emails Newsletters

NEWS ABOUT: Zetia

Zetia stories: 4 news summaries

Scientists Still Question Popular Drugs Zetia, Vytorin

Much-prescribed cholesterol medicines may not reduce risk of heart disease, death

Sep 2, 08 10:26 AM CDT

Scientists Still Question Popular Drugs Zetia, Vytorin

Much-prescribed cholesterol medicines may not reduce risk of heart disease, death

(Newser) - Some cholesterol medicines have shown no indication they actually work—but that hasn’t stopped doctors from heavily prescribing them, the New York Times reports. Short trials of Zetia and Vytorin, known generically as ezetimibe, showed no evidence they reduced risk of heart attack or cardiovascular disease, while tests raised... More »

Firms Hid Bad News on
Heart Drugs 2 Years: Doc

Merck and Schering-Plough delayed trial results on Vytorin, Zetia

Apr 1, 08 10:49 AM CDT

Firms Hid Bad News on Heart Drugs 2 Years: Doc

Merck and Schering-Plough delayed trial results on Vytorin, Zetia

(Newser) - A scientist hired by two drug companies to conduct trials of cholesterol-lowering drugs accused the firms of deliberately delaying release of the results, the New York Times reports. The results for the Vytorin and Zetia trials—which showed the drugs don't work to reduce plaque in arteries—were not released... More »

2 Top Cholesterol Drugs, Vytorin and Zetia, Don't Work

Cardiologists urge prescribing statins over Vytorin, Zetia

Mar 31, 08 3:55 AM CDT

2 Top Cholesterol Drugs, Vytorin and Zetia, Don't Work

Cardiologists urge prescribing statins over Vytorin, Zetia

(Newser) - Two top-selling cholesterol drugs  proved in a recent study to be largely ineffective in slowing the clogging of arteries, a panel of cardiologists said yesterday. Doctors should only prescribe Vytorin and Zetia if other medications don't work, and should rely instead on statins such as Lipitor and Zocor, they said.... More »

Generic Beats Pricey Pill on Cholesterol

Pharma stocks fall
after in-house study hails 3-cent drug

Jan 14, 08 5:42 PM CST

Generic Beats Pricey Pill on Cholesterol

Pharma stocks fall after in-house study hails 3-cent drug

(Newser) - A cheap generic drug cuts arterial buildup as well as a pricey pill and may threaten the growth of two drug companies, Bloomberg reports. Vytorin is produced by Merck & Co. and Schering-Plough Corp. and costs $2.84 per dose; simvastin, a generic, costs 3 cents a pill and works... More »

4 Stories




from our news partners

Please wait, content is loading
Please wait, content is loading